Search Results - "Harb, Diala E"

Effects of pancreatic enzyme replacement therapy (PERT) on overall survival (OS) in patients (pts) with advanced pancreatic ductal adenocarcinoma (APDAC) and evidence of pancreatic enzyme insufficiency (PEI): A single institution, retrospective, cohort study by Picozzi, Vincent J., Najjar, Anas, Harb, Diala E, Kort, Jens J, Mandelson, Meg T.

“…e16254 Background: Weight loss (WL)/cachexia is common in APDAC and associated with multiple adverse pt outcomes. Current NCCN guidelines recommend PERT in…”
Get full text

Effect of pancreatic enzyme replacement therapy (PERT) on body weight in advanced pancreatic cancer (APC) by Picozzi, Vincent J., Najjar, Anas, Harb, Diala E, Kort, Jens J, Mandelson, Meg T.

“…698 Background: Malnutrition/cachexia is common in PC and is associated with multiple adverse patient (pt) outcomes. Current NCCN guidelines recommend PERT in…”
Get full text

Impact of pancreatic enzyme replacement therapy (PERT) on clinical outcomes in nonresected pancreatic cancer (PC): Initial results by Picozzi, Vincent J., Hawari, Raneem, Najjar, Anas, Harb, Diala E, Kort, Jens J, Mandelson, Margaret T.

“…Abstract only 400 Background: Current NCCN guidelines recommend PERT use in PC patients (pts) with symptoms of EPI. However, little evidence exists regarding…”
Get full text